SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, DNA polymerase inhibitors for treating hepatitis B: a safety evaluation, Expert Opinion on Drug Safety, 2016, 15, 3, 383

    CrossRef

  2. 2
    Libin Jiang, Song Hu, Man He, Deying Tian, Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment, Hepatitis Monthly, 2016, 16, 1

    CrossRef

  3. 3
    Jung-ho Shin, Hee Jin Kwon, Hye Ryoun Jang, Jung Eun Lee, Geum-Youn Gwak, Wooseong Huh, Sin-Ho Jung, Joon Hyeok Lee, Yoon-Goo Kim, Dae Joong Kim, Ha Young Oh, Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents, Medicine, 2016, 95, 1, e2400

    CrossRef

  4. 4
    Yi-Chun Chen, Yu-Chieh Su, Chung-Yi Li, Shih-Kai Hung, 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan, BMC Nephrology, 2015, 16, 1

    CrossRef

  5. 5
    Jin-Lin Hou, Daozheng Xu, Guangfeng Shi, Mobin Wan, Zachary Goodman, Deming Tan, Qing Xie, Chengwei Chen, Lai Wei, Junqi Niu, Qinhuan Wang, Hong Ren, Yuming Wang, Jidong Jia, Weibin Bao, Yuhong Dong, Aldo Trylesinski, Nikolai V. Naoumov, Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B, Advances in Therapy, 2015, 32, 8, 727

    CrossRef